Mechanism-Based Treatment for Neonatal Seizures: Still on the Horizon

Overview

Journal Epilepsy Curr

Publisher Sage Publications

Date 2020 Oct 6

PMID 33021401

Citations 2

Authors

Carl E Stafstrom

Affiliations

Soon will be listed here.

Citing Articles

Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus.

Burman R, Rosch R, Wilmshurst J, Sen A, Ramantani G, Akerman C Nat Rev Neurol. 2022; 18(7):428-441.

PMID: 35538233 DOI: 10.1038/s41582-022-00664-3.

Don't Get BUM'd Out: Bumetanide May yet Prove Beneficial for Neonatal Seizures.

Stafstrom C Epilepsy Curr. 2021; 21(5):341-343.

PMID: 34924830 PMC: 8655264. DOI: 10.1177/15357597211032052.

References

Ben-Ari Y, Damier P, Lemonnier E . Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures. Front Cell Neurosci. 2016; 10:90. PMC: 4830840. DOI: 10.3389/fncel.2016.00090. View

Glykys J, Dzhala V, Egawa K, Balena T, Saponjian Y, Kuchibhotla K . Local impermeant anions establish the neuronal chloride concentration. Science. 2014; 343(6171):670-5. PMC: 4220679. DOI: 10.1126/science.1245423. View

Stafstrom C . Neonatal seizures: is a novel, mechanism-based treatment finally on the horizon?. Epilepsy Curr. 2007; 6(4):130-2. PMC: 1783437. DOI: 10.1111/j.1535-7511.2006.00121.x. View

Kahle K, Barnett S, Sassower K, Staley K . Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol. 2009; 24(5):572-6. DOI: 10.1177/0883073809333526. View

Cleary R, Sun H, Huynh T, Manning S, Li Y, Rotenberg A . Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures. PLoS One. 2013; 8(3):e57148. PMC: 3594228. DOI: 10.1371/journal.pone.0057148. View

Pressler R, Boylan G, Marlow N, Blennow M, Chiron C, Cross J . Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial. Lancet Neurol. 2015; 14(5):469-77. DOI: 10.1016/S1474-4422(14)70303-5. View

Khalilov I, Minlebaev M, Mukhtarov M, Khazipov R . Dynamic Changes from Depolarizing to Hyperpolarizing GABAergic Actions during Giant Depolarizing Potentials in the Neonatal Rat Hippocampus. J Neurosci. 2015; 35(37):12635-42. PMC: 6795198. DOI: 10.1523/JNEUROSCI.1922-15.2015. View

Khazipov R, Valeeva G, Khalilov I . Depolarizing GABA and developmental epilepsies. CNS Neurosci Ther. 2014; 21(2):83-91. PMC: 6495283. DOI: 10.1111/cns.12353. View

Thoresen M, Sabir H . Epilepsy: Neonatal seizures still lack safe and effective treatment. Nat Rev Neurol. 2015; 11(6):311-2. DOI: 10.1038/nrneurol.2015.74. View

10.

Kharod S, Kang S, Kadam S . Off-Label Use of Bumetanide for Brain Disorders: An Overview. Front Neurosci. 2019; 13:310. PMC: 6491514. DOI: 10.3389/fnins.2019.00310. View

11.

Dzhala V, Brumback A, Staley K . Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol. 2007; 63(2):222-35. DOI: 10.1002/ana.21229. View

12.

Sharpe C, Reiner G, Davis S, Nespeca M, Gold J, Rasmussen M . Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial. Pediatrics. 2020; 145(6). PMC: 7263056. DOI: 10.1542/peds.2019-3182. View